Keros to Repurchase 11 Million Shares in Oversubscribed Tender Offer

MT Newswires Live
2025/11/19

Keros Therapeutics (KROS) said Wednesday that it will repurchase almost 11 million shares at $17.75 each, or a total of $194.4 million, in a tender offer that expired on Tuesday.

The offer was oversubscribed, with about 16.7 million shares validly tendered and about 1.2 million shares tendered through notice of guaranteed delivery, the company said.

The shares to be acquired represent around 35.91% of the company's outstanding stock as of Tuesday, Keros said

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10